Skip to main content

EDITORIAL article

Front. Cardiovasc. Med., 17 April 2023
Sec. Cardiovascular Surgery
This article is part of the Research Topic Insights in Heart Surgery: 2022 View all 11 articles

Editorial: Insights in heart surgery: 2022

  • 1Cardiac Surgery F.U., Experimental and Clinical Medicine Department, University of Florence, Firenze, Italy
  • 2Clinic for Cardiovascular Surgery, Inselspital, University Hospital Bern, Bern, Switzerland
  • 3Division of Cardiac Surgery, Department of Surgery, Ohio State University Wexner Medical Center, Columbus, OH, United States
  • 4Department of Cardiac Surgery, Lankenau Institute for Medical Research, Main Line Health, Wynnewood, PA, United States

Editorial on the Research Topic
Insights in heart surgery: 2022

Cardiac surgery continues to evolve over the years beyond current challenges, technologies, and “traditional” outcomes. This collection of articles “Insights into cardiac surgery” aims to highlight the latest advances in the field of cardiac surgery achieved during 2022.

Surgical approaches in cardiac surgery experienced a tremendous evolution in the last two decades. A lot of changes happened since the first operation performed by Goldwin et al. in 1958 (1) to treat hypertrophic obstructive cardiomyopathy (HOCM), including the advent of the Bentall technique for aortic root pathology, and the first coronary aortic bypass grafting (CABG), which today is the most commonly cardiac surgery procedure performed worldwide.

Different approaches have been previously described to treat HOCM (2). Raffa et al. introducing a method with the involvement of the subvalvular mitral apparatus [resection of anomalous muscular trabecula, accessory papillary muscles (PM), secondary chordae, and splitting of PM], showed excellent results including freedom from repeat intervention of 96% and significant symptomatic relief with NYHA and left ventricular obstruction reduction during midterm follow-up as well as a reduction in terms of mitral valve regurgitation incidence and septal thickness.

On the other hand, among aortic root repair strategies, Chang et al. suggested in case of pathological features of dissection, a sinus replacement technique using a patch trimmed to a scallop shape similar to Valsalva sinus, aiming to decrease severe aortic root bleeding. However, a cornerstone like the Bentall procedure created a race on describing the benefits of the modified technique in large clinical studies (35). In this context, Werner et al. closed the gap regarding long-term outcomes in patients undergoing the modified Bentall technique operation evidencing comparable results at 10-year follow-up with those of the general population. In this cohort of patients, the prosthesis choice in the so-called “gray area” (50–70 years old) is still controversial. Certainly, the advancement of transcatheter procedures (TAVR) with valve-in-valve aortic replacement and even the stentless valve prostheses, should be considered in the need of a reintervention (6) such as in the case of a “matryoshka procedure” (7). As a matter of fact, Chan et al. for aortic valve replacement (SAVR), underlined that the use of biological aortic prostheses has increased significantly in recent years in all age groups while mechanical valves are still higher in patients requiring dialysis. Although SAVR is an effective treatment with very low in-hospital mortality, in the last years, SAVR's rate is reducing especially in patients with high risk, octogenarians, and those requiring redo surgery due to the advent of TAVR.

Despite the spread-out of percutaneous coronary revascularization (PCI) CABG remains the most common cardiac surgery procedure worldwide and the best option for multivessel disease to achieve complete revascularization. Pasierski et al. highlight the importance of complete revascularization even in patients with pre-existing AF showing improved long-term survival and a lower rate of reinterventions. The advent of new technologies for CABG has been shown to be a benefit in improving the outcomes and increasing the heterogeneity of the patients. In this context, grafts’ availability is undoubtedly the first component needed to perform a CABG. In case of the lack of suitable autologous bypass material, Fusco et al. describe tissue-engineered vascular grafts (20 cm in length with an inner diameter of 3 mm) tested in animal models that showed good patency after 4 weeks.

Achieved the best available grafts, even their storage during the procedure, become crucial. Szalkiewicz et al. compare the use of saline with autologous blood vs. a preventive solution formulated with an endothelial damage inhibitor. The use of the second solution in the saphenous vein storage and testing during distal anastomosis has been described to be associated with lower levels of troponin after the procedure demonstrating superiority in preserving tissue functionality.

Beyond the surgical technique, in the current clinical practice, periprocedural risk predictors and optimization of medical therapy become fundamental before surgery to achieve a good outcome and to offer a tailored patient approach (8). For example, after tricuspid valve surgery (TVS) mortality remains high. In this particular group of patients, periprocedural risk predictors that impact long-term prognosis have not been fully investigated yet. Hasimbegovic et al. set the tone and paved the pathway to the adjustment of pre-procedural secondary prevention and optimization of medical therapy in patients undergoing TVS. Their “real world” study evidenced how patients with a high estimated plasma volume status (ePVS) have a significant impact on long-term outcomes after TVS. In this context, the author reported that the ePVS and Duarte's PVC were significantly lower in survivors. Risk predictors for long-term prognosis also included ePVS and gamma-glutamyltransferase levels.

Now more than ever, cardiovascular surgery feels the need to set a balance between adequate pre-operative patient medical optimization, the correct surgical procedure based on individual patient profiles, and the desire of treating complex conditions pushing forward the boundaries of the achievable. All of the articles in this Collection inspire, inform, and provide guidance and direction to researchers in the field, and could help us understand where cardiac surgery is going.

In conclusion, even if technology progresses by leaps and bounds significantly influencing surgical techniques and results, we must keep in mind that clinical success can be achieved only by multidisciplinary teamwork that adapts the chosen surgical strategy to the specific clinical profile of the individual patient.

Author contributions

MB, FC, BB, HTS, RJC and AD contributed to conception and design of the study. MB, BB, and AD wrote the first draft of the manuscript. MB, FC, BB, and AD wrote the second draft of the manuscript. All authors contributed to manuscript revision, read, and approved the submitted version. All authors contributed to the article and approved the submitted version.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

References

1. Goodwin JF, Hollman A, Cleland WP, Teare D. Obstructive cardiomyopathy simulating aortic stenosis. Br Heart J. (1960) 22:403–14. doi: 10.1136/hrt.22.3.403

PubMed Abstract | CrossRef Full Text | Google Scholar

2. Dokollari A, Cameli M, Bisleri G, Pervez MB, Kalra DK, Demosthenous M, et al. Mitral Arcades Unexpectedly Encountered During Cardiac Surgery. J Cardiothorac Vasc Anesth. (2021) 35(3):914–6. doi: 10.1053/j.jvca.2020.10.018

PubMed Abstract | CrossRef Full Text | Google Scholar

3. Bonacchi M, Cabrucci F, Bacchi B, Haranal M, Gelsomino S, Ramlawi B, et al. Editorial: novel insights into aortic arch repair. Front Cardiovasc Med. (2022) 9:1087952. doi: 10.3389/fcvm.2022.1087952

PubMed Abstract | CrossRef Full Text | Google Scholar

4. Prifti E, Bonacchi M, Frati G, Proietti P, Giunti G, Babatasi G, et al. Early and long-term outcome in patients undergoing aortic root replacement with composite graft according to Bentall's Technique. Eur J Cardiothorac Surg. (2002) 21:15–21. doi: 10.1016/S1010-7940(01)01037-5

PubMed Abstract | CrossRef Full Text | Google Scholar

5. Bonacchi M, Dokollari A, Parise O, Sani G, Prifti E, Bisleri G, et al. Ministernotomy compared with right anterior minithoracotomy for aortic valve surgery. J Thorac Cardiovasc Surg. (2021):S0022-5223(21)00728-5. doi: 10.1016/j.jtcvs.2021.03.125

PubMed Abstract | CrossRef Full Text | Google Scholar

6. Dokollari A, Cameli M, Mandoli GE, Kalra DS, Poston R, Coku L, et al. Early and midterm clinical outcomes of transcatheter valve-in-valve implantation versus redo surgical aortic valve replacement for aortic bioprosthetic valve degeneration: two faces of the same medal. J Cardiothorac Vasc Anesth. (2021) 35(11):3223–31. doi: 10.1053/j.jvca.2021.05.029

PubMed Abstract | CrossRef Full Text | Google Scholar

7. Tomai F, Weltert L, de Persio G, Salatino T, de Paulis R. The matryoshka procedure. J Card Surg. (2021) 36(9):3381–3. doi: 10.1111/jocs.15718

PubMed Abstract | CrossRef Full Text | Google Scholar

8. Gelsomino S, Bonacchi M, Lucà F, Barili F, Del Pace S, Parise O, et al. Comparison between three different equations for the estimation of glomerular filtration rate in predicting mortality after coronary artery bypass. BMC Nephrol. (2019) 20(1):371. doi: 10.1186/s12882-019-1564-y

PubMed Abstract | CrossRef Full Text | Google Scholar

Keywords: advances and challenges, insight and practice, innovation, coronary revascularization surgery, valve repair and replacement, aortic surgery, HOCM

Citation: Bonacchi M, Bacchi B, Cabrucci F, Tevaearai Stahel H, Jeenchen Chen R and Dokollari A (2023) Editorial: Insights in heart surgery: 2022. Front. Cardiovasc. Med. 10:1184097. doi: 10.3389/fcvm.2023.1184097

Received: 11 March 2023; Accepted: 21 March 2023;
Published: 17 April 2023.

Edited and Reviewed by: Leonard Y. Lee, The State University of New Jersey, United States

© 2023 Bonacchi, Bacchi, Cabrucci, Tevaearai Stahel, Jeenchen Chen and Dokollari. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Massimo Bonacchi bWJvbmFjY2hpQHVuaWZpLml0

Specialty Section: This article was submitted to Heart Surgery, a section of the journal Frontiers in Cardiovascular Medicine

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.